Post Inflammatory Hyperpigmentation
14
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
90.0%
+3.5% vs benchmark
21%
3 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen
A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
The Efficacy of Bakuchiol in Treating PIH
Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face
Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation)
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
Nanofat on Wound Healing and Scar Formation
Tranexamic Acid vs Fractional CO2 Laser in Post-acne Hyperpigmentation
Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser
Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)